NCT01894399View on ClinicalTrials.gov

Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

HM61713

Cohort 1 : 100mg single dose in Korean Cohort 2 : 200mg single dose in Korean Cohort 3 : 300mg single dose in Korean Cohort 4 : 200mg single dose in Japanese Cohort 5 : 300mg single dose in Japanese Cohort 6 : 200mg single dose in Caucasian Cohort 7 : 300mg single dose in Caucasian

Trial Locations (1)

Unknown

Research Site, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01894399 - Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter